Carmell (NASDAQ:CTCX) Trading Down 8.5% – What’s Next?

Carmell Co. (NASDAQ:CTCXGet Free Report)’s share price dropped 8.5% on Friday . The company traded as low as $0.19 and last traded at $0.19. Approximately 385,686 shares were traded during trading, a decline of 87% from the average daily volume of 3,037,237 shares. The stock had previously closed at $0.21.

Carmell Trading Down 4.1 %

The business has a 50-day moving average price of $0.32 and a two-hundred day moving average price of $0.34.

Institutional Trading of Carmell

A hedge fund recently bought a new stake in Carmell stock. Citadel Advisors LLC purchased a new position in shares of Carmell Co. (NASDAQ:CTCXFree Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 187,565 shares of the company’s stock, valued at approximately $54,000. Citadel Advisors LLC owned 0.90% of Carmell at the end of the most recent quarter. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

About Carmell

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

See Also

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.